Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-13 7:58 pm Purchase | 2026-08-07 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Integrated Core Strategies (US) LLC | 6,316,545 5.500% | 279,546 (+4.63%) | Filing History |
| 2026-08-07 10:42 am Purchase | 2026-06-30 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | STATE STREET CORP STT | 6,051,771 5.300% | 6,051,771 (New Position) | Filing History |
| 2026-07-29 3:19 pm Purchase | 2026-06-30 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | BlackRock Inc. BLK | 7,776,940 6.800% | 2,525,577 (+48.09%) | Filing History |
| 2026-07-20 5:23 pm Purchase | 2026-07-13 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Integrated Core Strategies (US) LLC | 6,036,999 5.300% | 1,143,116 (+23.36%) | Filing History |
| 2026-06-30 5:36 pm Purchase | 2026-06-23 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Integrated Core Strategies (US) LLC | 4,893,883 4.300% | 4,893,883 (New Position) | Filing History |
| 2026-05-12 12:47 pm Sale | 2026-03-31 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Morgan Stanley MS | 2,959,296 2.600% | -1,502,597 (-33.68%) | Filing History |
| 2026-04-27 4:12 pm Purchase | 2026-03-31 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | BlackRock Inc. BLK | 5,251,363 4.600% | 1,211,389 (+29.99%) | Filing History |
| 2026-03-10 8:36 pm Purchase | 2026-02-20 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Avidity Partners Management LP | 6,049,999 5.300% | 3,208,975 (+112.95%) | Filing History |
| 2026-02-12 10:50 am Purchase | 2025-12-31 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Morgan Stanley MS | 4,461,893 6.000% | 4,461,893 (New Position) | Filing History |
| 2026-02-09 4:40 pm Purchase | 2026-02-02 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Commodore Capital LP | 11,939,753 9.900% | 8,589,753 (+256.41%) | Filing History |
| 2026-02-06 4:45 pm Purchase | 2026-02-03 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | TCG Crossover GP II, LLC | 7,915,567 6.900% | 7,915,567 (New Position) | Filing History |
| 2026-02-05 08:48 am Purchase | 2026-02-04 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Qatar Investment Authority | 7,073,308 6.200% | 7,073,308 (New Position) | Filing History |
| 2025-12-05 2:03 pm Sale | 2025-11-28 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | FMR LLC | 312,164 0.400% | -5,751,166 (-94.85%) | Filing History |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | FMR LLC | 6,063,330 8.200% | -3,432,895 (-36.15%) | Filing History |
| 2025-02-14 11:37 am Sale | 2024-12-31 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | JANUS HENDERSON GROUP Ltd. JHG | 17,839 0.000% | -4,781,513 (-99.63%) | Filing History |
| 2025-02-14 10:26 am Sale | 2024-12-31 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Avidity Partners Management LP | 2,841,024 4.200% | -749,402 (-20.87%) | Filing History |
| 2024-11-14 6:14 pm Purchase | 2024-09-30 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Avidity Partners Management LP | 3,590,426 5.300% | 3,590,426 (New Position) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Commodore Capital LP | 3,350,000 4.960% | -540,667 (-13.90%) | Filing History |
| 2024-11-14 10:24 am Purchase | 2024-09-30 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | JANUS HENDERSON GROUP Ltd. JHG | 4,799,352 7.100% | 4,799,352 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | BlackRock Inc. BLK | 4,039,974 6.000% | 0 (Unchanged) | Filing History |